Humana, Clover Soar On Medicare Advantage Star Rating; These Stocks Sink

Humana and Clover Health shares jumped after Medicare Advantage star ratings landed, according to Investor's Business Daily, with the key detail being a four-star rating that makes a big plan eligible for bonus payments in 2027.

The headline pairs the two names as winners on the ratings news, while "these stocks sink" signals that other Medicare Advantage names moved lower on the same day. The source does not name the decliners here, so the split itself is the takeaway: the ratings release produced clear winners and losers within a single group of insurers.

The concrete mechanism is the four-star threshold. Per the source, a four-star rating qualifies a big plan for bonus payments in 2027. Interpretation: because bonus eligibility hinges on that rating tier, a plan sitting at or above four stars gains a payment advantage over plans that fall short. That likely explains why investors rewarded Humana and Clover while selling other names, though the source ties the move to the ratings news, not to any specific earnings revision.

Worth noting for positioning: the bonus payments apply to 2027, so the benefit is a forward-looking funding advantage rather than an immediate earnings event. Traders are pricing a future payment stream, not a current-quarter beat.